Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLIMMER: Ecnoglutide (XW003) in Adults With Overweight or Obesity
NCT05813795Phase 3Completed
- Sponsor
- Sciwind Biosciences
- Start
- Apr 2023
- Primary completion
- Jun 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of ecnoglutide in obesity, Overweight, sponsored by Sciwind Biosciences. Started Apr 2023; status: completed.
02
Drugs
ecnoglutide
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT05813795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05813795.